Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Non-executive Director changes

18 Dec 2020 08:59

RNS Number : 1533J
Savills PLC
18 December 2020
 

18 December 2020

SAVILLS PLC

SAVILLS ANNOUNCES NON-EXECUTIVE DIRECTOR CHANGES

Savills plc, the international real estate advisor, is pleased to announce the appointments of Philip Lee and Richard Orders as additional Independent Non-Executive Directors with effect from 1 January 2021.

Savills also announces that Rupert Robson, who has served on the Board since 2015, will retire at the conclusion of the Company's 2021 AGM, currently scheduled for May 2021, and that Tim Freshwater, who has served on the Board since 2012, will retire from the Board on 31 December 2021. Tim, having served 9 years on the Board will also step down as Senior Independent Non-Executive Director effective 31 December 2020, when he will be replaced in this capacity by Stacey Cartwright.

Philip Lee is currently Vice Chairman of Global Banking, South East Asia, HSBC Bank and is a member of the Global Banking Vice Chairman and Banking Leadership Forums. He is also an independent board director of Heliconia Capital Management, an investment firm owned by Temasek focused on growth-oriented Singapore companies, and is Chairman of the Singapore Government's Health Promotion Board. Philip was previously with Deutsche Bank (2013-18), based in Singapore, as Vice Chairman of South East Asia and Chief Country Officer for the Bank. Prior to 2013, Philip was with JP Morgan (1995-2013), where he was CEO South East Asia Investment Banking and Chief Country Officer, Singapore, having worked in senior positions for various other banks in the region before then. Since 2006, he has also held roles on various advisory bodies established by the Singapore government.

Richard Orders is currently a managing director at Moelis & Company a leading global independent investment bank, heading the Firm's Hong Kong office having founded its predecessor firm, Asia Pacific Advisors, in 2009. Prior to this, Richard was with ABN AMRO (1996-2008), latterly from 2004-8 as Vice Chairman and Head of Global Clients Asia, having previously been Executive Chairman and CEO of ABR AMRO Asia Corporate Finance. Previously, Richard held various roles in Barings Bank, which he joined in 1976, latterly as Head of Barings Investment Banking business in Asia, ex Australia and Japan (1994-96) and Director of Barings Corporate Finance London (1996).

There is no further information which would require disclosure under 9.6.13R of the Listing Rules of the UK Listing Authority in respect of either Philip Lee or Richard Orders.

Commenting on the changes, Nicholas Ferguson, Chairman of Savills plc said : "We are delighted that Philip and Richard are joining the Board so that Savills can benefit from their extensive experience. I also want to thank Rupert Robson and Tim Freshwater very warmly for their enormous contribution to the Board over so many years". 

For further information please contact:

Mark Ridley 020 7409 8934

Simon Shaw 020 7409 8934

David Allchurch /

Elizabeth Snow - Tulchan 020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVWRRWUUARA
Date   Source Headline
24th Nov 20223:25 pmRNSDirector/PDMR Shareholding
14th Nov 20229:29 amRNSDirector/PDMR Shareholding
11th Oct 20224:21 pmRNSDirector/PDMR Shareholding
10th Oct 20224:36 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:24 pmRNSDirector/PDMR Shareholding
1st Sep 202210:07 amRNSTotal Voting Rights
31st Aug 202210:00 amRNSDirector/PDMR Shareholding
16th Aug 20223:33 pmRNSBlock listing Interim Review
16th Aug 202211:12 amRNSDirector/PDMR Shareholding
11th Aug 20224:12 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSHalf-year Report
12th Jul 20223:34 pmRNSDirector/PDMR Shareholding
1st Jul 20223:56 pmRNSDirector/PDMR Shareholding
1st Jul 202210:00 amRNSTotal Voting Rights
20th Jun 20224:33 pmRNSHolding(s) in Company
17th Jun 20227:29 amRNSHolding(s) in Company
15th Jun 202212:00 pmRNSHolding(s) in Company
10th Jun 20223:46 pmRNSHolding(s) in Company
1st Jun 20222:22 pmRNSHolding(s) in Company
1st Jun 202210:00 amRNSTotal Voting Rights
31st May 20222:53 pmRNSHolding(s) in Company
27th May 202210:00 amRNSHolding(s) in Company
26th May 20223:56 pmRNSDirector/PDMR Shareholding
17th May 20225:17 pmRNSHolding(s) in Company
17th May 20225:12 pmRNSHolding(s) in Company
11th May 20225:44 pmRNSDirector/PDMR Shareholding
11th May 20222:22 pmRNSResult of AGM
11th May 20229:56 amRNSAGM Statement
3rd May 20227:00 amRNSTotal Voting Rights
27th Apr 20224:13 pmRNSDirectors Remuneration Report - Clarification
21st Apr 20224:57 pmRNSDirector/PDMR Shareholding
21st Apr 20224:44 pmRNSHolding(s) in Company
12th Apr 20222:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:28 pmRNSAnnual Report and AGM Notice
1st Apr 202210:00 amRNSTotal Voting Rights
14th Mar 202210:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSFinal Results
3rd Mar 202211:00 amRNSTotal Voting Rights
15th Feb 202211:00 amRNSBlock listing Interim Review
14th Feb 202212:00 pmRNSDirector/PDMR Shareholding
1st Feb 202210:27 amRNSTotal Voting Rights
21st Jan 202210:00 amRNSBlock listing Interim Review
12th Jan 20227:00 amRNSYear End Trading Update
11th Jan 20223:04 pmRNSDirector/PDMR Shareholding
4th Jan 202211:19 amRNSTotal Voting Rights
31st Dec 202110:06 amRNSSavills IM & Samsung Life Investment Alliance
13th Dec 202112:38 pmRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSTotal Voting Rights
25th Nov 202112:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.